James Macdonald, MD
Adult Reconstructive Orthopaedic Surgery · Annapolis, MDNPI 1184628794
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $22,631 of the $24,750 with a category attached, or 91.4%. Smith+Nephew accounts for 95.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $14,620 and has fallen 99.0% since, to $142 in 2025.
Across 41 payments — averaging $603.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$24K
- Davol Inc.$405
- Zimmer Biomet$392
- Johnson & Johnson$111
- Pacira Pharmaceuticals Incorporated$68
- Medacta USA, Inc.$64
- plus $45 from 3 others
Across 69 payments — averaging $4456.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$307K
What the payments were for
- Speaking & faculty fees$22,63191%
- Food & beverage$2,1189%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 24 | $23,664 |
| Davol Inc. | 3 | $405 |
| Zimmer Biomet | 4 | $392 |
| Johnson & Johnson | 3 | $111 |
| Pacira Pharmaceuticals Incorporated | 3 | $68 |
| Medacta USA, Inc. | 1 | $64 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $15 |
| Heraeus Medical, LLC. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$23,446
- POLARSTEM$10,425
- REAL INTELLIGENCE$7,908
- BIRMINGHAM HIP$7,831
- Tandem$7,800
- CORI$7,613
- Anthology$6,014
- LEGION TKS$5,425
- POLAR3$5,156
- Journey II BCS$4,813
- Journey II CR$4,813
- JOURNEY II UK$4,813
- REDAPT$2,625
- OR3O$2,406
- SYNERGY$2,406
- R3$700
- Legion Revision$233
- ROSA-Knee$142
- Connected Health Product Portfolio$121
How this compares
$24,750 in reported general payments places this provider in the 65th percentile of 33 adult reconstructive orthopaedic surgery providers in Maryland.
See all adult reconstructive orthopaedic surgery providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 13 | $5,675 |
| Amoxicillin | 19 | $37 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Annapolis
- Paul KingAnnapolis$21K
- Kelly KilcoyneAnnapolis$10K
- Michael AnvariAnnapolis$8K
- Marc BrassardAnnapolis$0
- Michael MontBaltimore$10.9M
- Randal LewisChevy Chase$2.6M
- Sridhar DurbhakulaBethesda$766K
- Pasquale PetreraSalisbury$137K
- Pablo WagnerBaltimore$118K
- James NaceBaltimore$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.